Publications
List of Publications
Our publications in peer-reviewed journals are just one of the ways in which we aim to contribute to the ever-growing base of knowledge in the field of health economics. Explore our past publications in a wide range of therapeutic areas below.
The Burden Patients with Myasthenia Gravis Experience in Terms of Breathing, Fatigue, Sleep, Mental Health, Discomfort and Usual Activities in Comparison to the General Population
Dewilde, S., Tollenaar, N.H.,
Phillips, G., Paci, S., De Ruyck, F., Janssen, M.F. (2023)
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies
Dewilde, S., Tollenaar, N.H.,
Phillips, G., Paci, S., De Ruyck, F.,& Janssen, M. F. (2023)
Concordance between patient- and physician-reported Myasthenia Gravis Activities of Daily Living (MG-ADL) score
Dewilde, S., Tollenaar, N.H.,
Janssen, M. F.,Vanoli, F., Frangiamore, R., Phillips, G., Paci, S., Mantegazza, R., Meisel, A., & Stascheit, F. (2023).
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
Dewilde, S.,
Philips, G., Paci, S., Beauchamp, J., Chiroli, S., Quinn, C., Day, L., Larkin, M., Palace, J., Berrih-Aknin, S., Claeys, K. G., Muppidi, S., Mantegazza, R., Saccà, F., Meisel, A., Bassez, G., Murai, H., & Janssen, M. F.(2023)
A dashboard for the evaluation of the effect of school closures on wellbeing of children and parents
Brackx, F.,
De Smedt, B. & Molenberghs, G.(2023)
An EQ-5D-Y-3L Value Set for Belgium. PharmacoEconomics
Dewilde, S., Tollenaar, N.H.,
Roudijk, B., & Ramos-Goñi, J. M. (2022)
Exploration of the Reasons Why Health State Valuation Differs for Children Compared With Adults: A Mixed Methods Approach
Dewilde, S.,
Janssen MF, Lloyd AJ, Shah K.(2022)
The Effect of Transborder Mobility on COVID-19 Incidences in Belgium. International journal of environmental research and public health
Brackx, F.,
Vanongeval, F., Natalia, Y.A., Molenberghs, G., & Steenberghen, T. (2022)
Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain. The Patient-Patient-Centered Outcomes Research
Dewilde, S.,
Estévez-Carrillo, A., Oppe, M., & Ramos-Goñi, J. M. (2022)
Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG)
Dewilde, S.,
Sonia Berrih-Aknin, Kristl G. Claeys, Nancy Law, Renato Mantegazza, Hiroyuki Murai, Francesco Saccà, et al.(2021)
Thrombectomy is a cost-saving procedure up to 24 h after onset
Dewilde, S.
Nivelle, E, Peeters, A, Vanhooren, G, Thijs, V. (2021)
Estimating health state utilities in hemophagocytic lymphohistiocytosis
Dewilde, S.,
Nafees, B., Lloyd, A., & (2021)
Evaluation of the cost-effectiveness of dexrazoxane for the prevention of anthracycline-related cardiotoxicity in children with sarcoma and haematologic malignancies: a European perspective
Dewilde, S.,
Carroll K, Nivelle E, Sawyer J. (2020)
The combined impact of dependency on caregivers, disability and coping strategy on quality of life after ischemic stroke
Dewilde, S.
Annemans L, Lloyd A, Belgian Stroke Council. (2019)
The Relationship between home-time, quality of life and costs after ischemic stroke: The impact of the need for mobility aids, home and car modifications on home-time
Dewilde, S.,
Annemans L, Belgian Stroke Council. (2018)
Hospital financing of ischaemic stroke: determinants of funding and usefulness of DRG subcategories based on Severity of Illness
Dewilde, S.,
Annemans L, Pince H, Thijs V. (2018)
What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients' Quality of Life?
Dewilde, S.
Lloyd AJ,Noble S, Reimer E, Lee AYY. (2018)
Health state utilities in non-small cell lung cancer: An international study
Dewilde, S.,
Nafees B, Lloyd AJ, Rajan N, Lorenzo M. (2017)
Modified Rankin scale as a determinant of direct medical costs after stroke
Dewilde, S.,
Annemans L, Belgian Stroke Council. (2017).
The impact of cancer-associated thrombosis and treatment related bleedings on patients' quality of life
Dewilde, S.
Noble S, Lloyd A, Reimer E, Lee A. (2016).
Health state utilities in non-small cell lung cancer: An international study
Dewilde, S.,
Nafees B, Lloyd AJ, Rajan N, Lorenzo M. (2016)
Analysis of primary and secondary APR-DRG codes of an ischemic stroke admission
Dewilde, S.,
Annemans L, Thijs V. (2015)
The relationship between Severity of Illness and the modified Rankin Scale in ischemic stroke patients with response mapping
Dewilde, S.
Annemans L, Thijs V.(2015)
Utilities for treatment-related adverse events in type 2 diabetes
Dewilde, S.,
S. Shingler, B. Fordham, M. Evans, M. Schroeder, G. Thompson, & A. J. Lloyd.(2015)
Place of residence and employment status after stroke
Dewilde, S.,
Peeters A, Thijs V, Annemans L, Belgian Stroke Council. (2014)
Quality of Life Decrements after Stroke
Dewilde, S.
Peeters A, Thijs V, Annemans L, Belgian SC. (2014)
Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales
Dewilde, S.,
Woods B, Castaigne JG, Parker C, Dunlop W. (2014)
Investigating Incoherence Gives Insight: the case of anti-platelet therapy for stroke prevention
Dewilde, S.,
Hawkins N.(2012)
Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis: A Discrete-Choice Experiment
Dewilde, S.
Hodgkins P, Swinburn P, Solomon D, Yen L, Lloyd A.(2012)
Cost-effectiveness of adjunctive eptifibatide in patients undergoing coronary stenting in Germany
Dewilde, S.,
Brüggenjürgen B,
Nienaber C, Senges J, Welte R,
Willich SN.(2012)
Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: heterogeneity in parent preferences
Dewilde, S.,
Lloyd A, Hodgkins P, Sasané R, Falconer S, Sonuga Barke E.(2011)
Cost of hospitalization for cerebrovascular disorders in Belgium
Dewilde, S.
Thijs V, Putman K, Pince H.(2011)
Eliciting health state utilities from the general public for severe chronic pain
Dewilde, S.,
Eldabe S, Lloyd A, Verdian L, Meguro M, Maclaine G.(2010)
Cost-effectiveness of warfarin: Trial versus ‘real-life’ stroke prevention in atrial fibrillation
Dewilde, S.,
Sorensen SV, Singer DE,
Goldhaber SZ, Wolf PA,
Monz BU, Plumb JM.(2009)
Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer
Dewilde, S.
Lloyd A, Penson D, Kleinman L.(2008)
Preferences and utilities for the symptoms of moderate to severe allergic asthma
Dewilde, S.,
Lloyd A, Doyle S, Turk F.(2008)
The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden
Dewilde, S.,
Turk F, Tambour M, Sandström T.(2006)
Health state utilities for metastatic breast cancer
Dewilde, S.
Lloyd A, Nafees B, Narewska J.(2006)
Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma
Dewilde, S.,
Niebauer K, Fox Rushby J, Revicki DA.(2006)
The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer
Dewilde, S.,
Anderson R (2004)
Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery
Dewilde, S.
Flameng WJ, Herijgers P, Lesaffre E. (2003)